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The association of p-synephrine, ephedrine, salicin, and caffeine in dietary supplements and weight loss 
products is very common worldwide, even though ephedrine has been prohibited in many countries. 
The aim of this study was to evaluate a 28-day oral exposure toxicity profile of p-synephrine, ephedrine, 
salicin, and caffeine mixture (10:4:6:80 w/w respectively) in male and female Wistar rats. Body weight 
and signs of toxicity, morbidity, and mortality were observed daily. After 28 days, animals were euthanized 
and blood collected for hematological, biochemical, and oxidative stress evaluation. No clinical signs 
of toxicity, significant weight loss or deaths occurred, nor were there any significant alterations in 
hematological parameters. Biochemical and oxidative stress biomarkers showed lipid peroxidation, and 
hepatic and renal damage (p < 0.05; ANOVA/Bonferroni) in male rats (100 and 150 mg/kg) and a reduction 
(p < 0.05; ANOVA/Bonferroni) in glutathione (GSH) levels in all male groups. Female groups displayed 
no indications of oxidative stress or biochemical alterations. The different toxicity profile displayed by 
male and female rats suggests a hormonal influence on mixture effects. Results demonstrated that the 
tested mixture can alter oxidative status and promote renal and hepatic damages.
Uniterms: p-Synephrine/toxicity profile. Ephedrine/toxicity profile. Salicin/toxicity profile. Caffeine/
toxicity profile. Dietary supplements/evaluation. Weight loss products/evaluation.
A associação de p-sinefrina, efedrina, salicina, e cafeína em suplementos alimentares e produtos para 
perda de peso é muito utilizada em todo o mundo, embora a efedrina tenha sido proibida em muitos 
países. O objetivo deste estudo foi avaliar o perfil de toxicidade à exposição oral de 28 dias à associação 
de p-sinefrina, efedrina, salicina e cafeína (na proporção de 10:4:6:80 m/m respectivamente) em ratos 
Wistar machos e fêmeas. Diariamente, os animais foram observados quanto ao peso corporal, sinais de 
toxicidade, morbidade e mortalidade. Após 28 dias, os animais foram sacrificados e o sangue coletado 
para avaliações hematológicas, bioquímicas e de estresse oxidativo. Não se observaram sinais clínicos 
de toxicidade, tampouco perda significativa de peso, mortes, ou quaisquer alterações significativas nos 
parâmetros hematológicos. Biomarcadores do estresse oxidativo e bioquímicos mostraram peroxidação 
lipídica, danos renais e hepáticos (p < 0,05; ANOVA/Bonferroni) em ratos machos (100 e 150 mg/kg) e 
a redução (p < 0,05; ANOVA/Bonferroni) nos níveis de glutationa reduzida (GSH) em todos os grupos 
de machos tratados. Nas fêmeas, não houve indícios de estresse oxidativo, nem alterações bioquímicas. 
O diferente perfil de toxicidade entre os gêneros sugere influência hormonal nos efeitos de mistura 
administrada. A associação testada pode alterar o estado oxidativo e promover danos renais e hepáticos.
Unitermos: p-Sinefrina/perfil de toxicidade. Efedrina/perfil de toxicidade. Salicina/perfil de toxicidade. 
Cafeína/perfil de toxicidade. Suplementos alimentares/avaliação. Produtos para perda de peso/avaliação.
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INTRODUCTION
Overweight and obesity are highly prevalent 
worldwide. Many consumers are seeking strategies 
for reducing weight to healthier levels, including the 
use of dietary supplements and weight loss products. 
These products typically stimulate or enhance weight 
loss through mechanisms such as reducing hunger or 
increasing resting metabolism (Dwyer et al., 2005). 
There are a large number of products being marketed 
for weight loss, most usually containing a mixture of 
ingredients including p-synephrine (Citrus aurantium 
L.), ephedrine (Ma Huang, Ephedra sinica, Ephedra sp.), 
salicin (Salix sp.) and caffeine (Paullinia cupana, Cola 
nitida, Cola acuminata, Camellia sinensis), as well as 
vitamins, minerals, and other herbs (Arbo et al., 2008, 
2009a, 2009b).
Ephedrine is an adrenergic agonist for both α 
and β receptors affecting both the cardiovascular and 
central nervous system (Schaneberg et al., 2003). The 
use of p-synephrine, a biogenic amine found in Citrus 
aurantium, became very popular after the banning of 
ephedrine-containing dietary supplements by the Food 
and Drug Administration (FDA) due to the occurrence 
of significant adverse effects, mainly related to the 
cardiovascular system (Bouchard et al., 2005). It quickly 
replaced ephedrine in supplements called “ephedra-free” 
due to their structural similarity (Fugh-Berman, Myers, 
2004; Jordan et al., 2004; Grollman, 2005).
However, like ephedrine, p-synephrine is an α 
and β adrenergic agonist and both are structurally and 
pharmacologically related to amphetamines (Firenzuoli et 
al., 2005) and other adrenergic amines such as epinephrine 
and norepinephrine (Rossato et al., 2011a). For this 
reason, it is believed that it may also cause adverse effects, 
especially on the cardiovascular system (Bouchard et 
al., 2005). On the other hand, Rossato et al. (2011b) 
observed that only m-synephrine (positional isomeric 
form of synephrine) induced a potentially toxic effect, 
while p-synephrine showed negligible cardiotoxicity 
in an in vitro model. Arbo et al. (2008, 2009a, 2009b) 
demonstrated that extracts of both C. aurantium and 
isolated p-synephrine showed low toxicity in mice, even 
at high doses.
These facts therefore lead us to believe that reports of 
toxicity from this amine could be related to its association 
with other substances, specifically caffeine, salicin and 
even ephedrine in many products (Schmitt et al., 2012).
Although ephedrine has been banned or restricted in 
several countries, it can be found in some formulations due 
to adulterations to improve product performance (Schmitt 
et al., 2012). Caffeine, a stimulant with α-adrenergic-like 
properties, acts on cardiovascular system (Kalman et al., 
2002) and may enhance the effects of sympathomimetics 
such as ephedrine (Astrup et al., 1992; Haller et al., 2004) 
and probably synephrine (Schmitt et al., 2012) because 
their structural similarities (Pellati and Benvenuti, 2007).
Salicin is a phenolic glycoside extracted from 
Salix sp. (white willow bark), which displays analgesic 
properties (Zaugg et al., 1997), but there is no scientific 
support for its presence in weight loss formulations. It is 
believed to enhance the effects of other substances in a 
synergistic pathway, extending or increasing the activity 
of thermogenic ingredients through prolonging ephedrine 
action time (Schmitt et al., 2012). Acetylsalicylic acid, 
which belongs to the same salicylate family as salicin, 
showed increases in the thermogenesis effects of both 
ephedrine and caffeine in obese women (Horton, Geissler, 
1991).
The association of p-synephrine with ephedrine, 
salicin, and caffeine is found in several marketed 
products, and it is known that the association of similarly 
acting substances can increase and/or strengthen their 
pharmacological actions. Acute toxicity of this association 
was seen by Schmitt et al. (2012). However, these products 
are usually consumed over long periods and it is necessary 
to evaluate the effects after repeated doses. The aim of 
this study was to evaluate 28 days oral exposure to a 
mixture of p-synephrine, ephedrine, salicin and caffeine 
(10:4:6:80 w/w respectively) in male and female rats and 
their actions on oxidative stress biomarkers. The relative 
proportions of the substances in the mixture were based 
on several weight loss products available on the market. 
However, this does not linearly correspond to products 
used by humans because proportions and dose indications 
vary greatly from product to product.
MATERIAL AND METHODS
Chemicals and reagents
Chemicals and reagents were obtained thus: 
(±)-p-synephrine (99%) from MP Biomedicals (California, 
USA); ephedrine (99.5%) from Aldrich (St. Louis, USA); 
salicin (99%) from FlukaBioChemika (Switzerland); 
caffeine (99%) from Merck (Darmstadt, Germany);5,5’-
dithio-bis(2-nitrobenzoic acid) from Sigma (St. Louis, 
MO, USA);and HPLC grade acetonitrile, methanol and 
n-butanol from the Tedia Company (Fairfield, USA). 
Water was purified using a Milli-Q system (Millipore, 
Bedford, USA). All other chemicals were of analytical 
grade.
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Animals
Experiments were performed after approval from 
the University Ethics Committee (deliberation number 
2007982) and were carried out in accordance with current 
guidelines for the care of laboratory animals (Goldim, 
Raymundo, 1997; Olfert et al., 1998). Male and female 
Wistar rats, weighing 306.3 ± 24.5 g and 196.9 ± 17.6 g 
respectively, were obtained from Central Animal House 
of the Institute of Basic Health Sciences, Federal 
University of Rio Grande do Sul. Animals were housed 
in 47 × 34 × 18 cm polyethylene cages under standard 
temperature conditions (22 ± 2 °C), controlled humidity, 
and a 12 h light/dark cycle. All experimental procedures 
were performed during the light phase of the cycle.
Repeated dose 28-day oral toxicity study
The exper imenta l  p ro tocol  was  based  on 
OECD (Organization for Economic Co-operation and 
Development) guideline 407 (Repeated Dose 28-day 
Oral Toxicity Study in Rodents). The experiment was 
conducted distributing the rodents in groups of 8 male and 
8 female rats each. Animals were treated by oral gavage for 
28 consecutive days with water (control) or 50, 75, 100, 
and 150 mg/kg of an aqueous mixture of p-synephrine, 
ephedrine, salicin and caffeine (proportion of 10:4:6:80 
w/w respectively) administered at a constant volume of 
10 mL/kg. The substance proportions in the mixture were 
defined considering several weight loss products available 
in the market.
Body weight was measured every day and animals 
were observed daily for signs of toxicity, morbidity, 
and mortality. At the end of the experiment, animals 
were euthanized with ketamine/xylazine (50 mg/kg and 
10 mg/kg respectively) and necropsied. Selected organs 
(heart, liver, lung, brain, spleen, kidneys, and adrenal 
glands) were collected and observed for macroscopic 
alterations.
Biochemical and hematological analysis
After euthanasia, blood was collected from caudal 
vein using heparin or EDTA as anticoagulant for 
biochemical and hematological evaluations. In whole blood 
with EDTA, hemoglobin and hematocrit were performed 
according to ICHS (1978) and ICHS (1982) respectively. 
Part of the blood was centrifuged and heparinized plasma 
used to evaluated alanine aminotransferase (ALT), 
aspartate aminotransferase (AST) and creatinine using 
commercial kits (Labtest Diagnóstica).
Oxidative stress biomarker evaluations
Part of the blood collected with anticoagulant was 
centrifuged at 1500g for 10 minutes and immediately 
separated into plasma and erythrocytes. EDTA plasma 
was used to evaluate lipid peroxidation through an HPLC 
method with visible detection at 532 nm (Grotto et al., 
2007). This method quantifies malondialdehyde (MDA) 
levels after alkaline hydrolysis and extraction with 
n-butanol. Erythrocytes were used to determinate reduced 
glutathione (GSH), which was measured as non-protein 
thiols, according to Ellman (1959) modified. Aliquots 
(0.3 mL) of erythrocytes were added to a phosphate 
buffer 0.3 M (0.85 mL), pH 7.4 and the reaction was read 
in spectrophotometer at 412 nm after addition of 10 mM 
5,5’-dithiobis(2-nitrobenzoic) acid (DTNB) (0.05 mL). 
The results were expressed as µmol/mL erythrocytes.
The whole blood collected with heparin was used 
to analyze antioxidant enzyme glutathione peroxidase 
(GPx) activity using glutathione reductase and NADPH. 
The method is based on the oxidation of NADPH, which 
is indicated by a decrease in absorbance at 340 nm (Paglia, 
Valentine, 1967).
Statistical analysis
Data were expressed as mean ± SEM (standard 
error of mean). Organ weights were determined and 
expressed as relative weight and were analyzed by one-
way analysis of variance (ANOVA). Body weight gain 
was evaluated by repeated measures ANOVA. Relative 
body weight gain was obtained considering initial weight 
measurement as 100% and all gain was compared to the 
initial measurement. Differences between groups were 
evaluated by one-way ANOVA, followed by post hoc 
Bonferroni, when appropriate. The significance level was 
set at 5% (p < 0.05).
RESULTS AND DISCUSSION
Daily oral exposure (28 days) of p-synephrine 
associated to ephedrine, salicin and caffeine in male and 
female rats did not show signs of toxicity; there were also 
no deaths of either male or female rats during the 28-day 
experimental period. This suggests that the tested doses 
(50, 75, 100, and 150 mg/kg) presented low toxicity. In 
previous studies with mice, higher doses (300, 350, and 
400 mg/kg) of the mixture, showed clear signs of toxicity 
including death, especially in males (Schmitt et al., 2012).
Body weight did not significantly change during the 
28-day toxicity test. However, it was possible to observe that 
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body weight gain was higher in females than males (Figure 1). 
Necropsy showed no changes in relative organ weights and 
no macroscopic alterations in either male or female rats.
Animals did not lose weight in contrast to the 
purported aims of the products. Interestingly, the results 
revealed a different profile between genders. Females 
showed more body weight gain, demonstrating them as 
less susceptible to the effects of the mixture. This fact 
could be related to hormonal differences between males 
and females; further studies focusing on hormones could 
elucidate this point.
Hematological and biochemical analysis results 
are presented in Table I. No significantly alterations were 
observed in male or female rat hematological parameters. 
Biochemical analysis revealed increases (p < 0.05) in 
AST, ALT, and creatinine levels in male rats treated with 
100 and 150 mg/kg of the mixture. However, there was a 
significant decrease (p < 0.05) in AST for female groups 
treated with 100 and 150 mg/kg of the mixture.
Males displayed an upward trend in both AST 
and ALT enzyme levels as dose increased. According to 
adopted reference values, AST is normal whereas ALT 
is increased and may indicate some liver damage. In the 
same way, creatinine levels in all male treated groups 
showed a progressive increase, which was significantly 
higher in the 100 and 150 mg/kg treated groups compared 
to controls (p < 0.05). It was also outside the normal range 
(0.2-0.6 mg/dL) for male Wistar rats (Giknis, Clifford, 
2008) indicating possible renal damage. Although there 
is undeniable evidence of the nephrotoxic effects of the 
mixture, the mechanism responsible is unclear. It may be 
caused by a similar mechanism to amphetamines, whose 
vasoconstrictor properties predispose the renal medulla to 
ischemia and hypoxia. In addition, there could be direct 
toxic effects from the drugs and/or their metabolites, as 
well as enhanced oxidative stress in the kidney (Carvalho 
et al., 2012).
The liver is a target for amphetamines and their 
analogues (as in the case of synephrine and ephedrine) 
since they are biotransformed primarily in this organ, 
as is caffeine. During the biotransformation process 
(e.g. 3,4-Methylenedioxy-methamphetamine -MDMA, 
TABLE I - Hematological and plasmatic biochemical parameters evaluated in male and female Wistar rats after 28 days of treatment 
with a mixture of p-synephrine, ephedrine, salicin and caffeine (10:4:6:80 w/w)
Parameters
MALE FEMALE
Control 50 mg/kg 75 mg/kg 100 mg/kg 150 mg/kg Control 50 mg/kg 75 mg/kg 100 mg/kg 150 mg/kg
Hematocrit (%) 41.9 ± 1.1 43.4 ± 1.7 44.7 ± 1.3 43.5 ± 1.3 44.4 ± 1.0 40.7 ± 0.7 40.3 ± 0.7 41.5 ± 0.4 41 ± 0.8 43.1 ± 0.9
Hemoglobin (g/dL) 17.0 ± 0.4 17.3 ± 0.9 16.8 ± 1.1 16.7 ± 0.8 17.2 ± 0.5 14.1 ± 0.3 13.8 ± 0.3 14.7 ± 0.2 14.2 ± 0.9 14.1 ± 0.4
AST (U/mL) 66.8 ± 5.2 77.6 ± 8.3 99.4 ± 6 124.3 ± 17.3* 147 ± 19.6* 135.5 ± 17 114.1 ± 7.7 94.4 ± 3.8 87.1 ± 6.6* 86.6 ± 6.7*
ALT (U/mL) 35.7 ± 3.7 34.1 ± 2.8 43.7 ± 3.5 62 ± 5.8* 87.3 ± 12.2* 53.4 ± 10.6 54.8 ± 4.4 50.1 ± 2.1 59.0 ± 5.1 46.7 ± 7.6
Creatinine (mg/dL) 0.27 ± 0.02 0.48 ± 0.06 0.53 ± 0.04 0.65 ± 0.09* 0.65 ± 0.14* 0.4 ± 0.06 0.48 ± 0.06 0.57 ± 0.05 0.49 ± 0.04 0.6 ± 0.06
Data are expressed as mean ± standard error of the mean (n=6-8 males and 6-8 females per group). *Significantly different from their respective gender control 
group (p < 0.01) by ANOVA/Bonferroni. AST: aspartate aminotransferase; ALT: alanine aminotransferase
FIGURE 1 - Relative body weight gain in Wistar rats male (A) 
and female (B) after oral treatment for 28 consecutive days 
with p-synephrine associated to ephedrine, salicin and caffeine 
(10:4:6:80 w/w). Each point represent the mean ± standard error 
of the mean (n=8).
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a hallucinogenic amphetamine) free radicals can be 
generated (Carvalho et al., 2004) and cause liver damage. 
Custodio et al. (2010) studied mitochondria involvement 
in MDMA and 4-methylthioamphetamine (MTA) 
produced liver toxicity and found that, depending on dose, 
both amphetamine derivatives (especially MTA in high 
concentrations) cause mitochondrial dysfunction, which 
is another mechanism for hepatotoxicity. 
Hepatic enzyme alterations in female groups 
were opposite to those in male groups; their AST values 
significantly decreased in the 100 and 150 mg/kg treated 
groups related to controls (p < 0.01). However, the 
values were within normal limits for female Wistar rats 
(63-175 U/L) (Giknis, Clifford, 2008).
There are many reports of gender being a critical 
factor in drug-induced liver injury (Hemieda, 2007; 
McConnachie et al., 2007; Dever, Elfarra, 2008). 
Moreover, most of those reports demonstrate that males 
were more susceptible to hepato toxin-induced liver injury 
than females. Studies have reported that bioactivation 
and estrogen concentration are mainly responsible 
for the gender-dependent discrepancy in liver injury 
(McConnachie et al., 2007; Dever, Elfarra, 2008; Liang 
et al., 2011). Also, gender differences in pharmacokinetics 
and pharmacodynamics characterize many drugs and 
contribute to individual differences in drug efficacy and 
toxicity. Drug metabolism is the primary cause of gender-
dependent pharmacokinetics and reflects underlying 
gender differences in the expression of hepatic enzymes 
active in the metabolism of drugs, steroids, fatty acids, 
and environmental chemicals, including cytochrome 
P450 enzymes (P450s), sulfotransferases, glutathione 
transferases, and UDP-glucuronosyl transferases. Studies 
in rat and mouse liver models have identified more than 
1000 genes whose expression is gender-dependent; 
together, these genes impart substantial sexual dimorphism 
on liver metabolic function and pathophysiology 
(Waxman, Holloway, 2009).
Arbo et al., (2009a) tested Citrus aurantium extracts 
(400, 2000, or 4000 mg/kg corresponding to 30, 150, and 
300 mg/kg of p-synephrine, respectively) and p-synephrine 
(30 and 300 mg/kg) in male mice daily for 28 days and 
found no changes in biochemical parameters ALT, AST, 
or creatinine. This result can in fact corroborate that 
associating p-synephrine with others substances promotes 
physiological alterations, as the doses of the tested mixture 
were 50, 75, 100, and 150 mg/kg, corresponding to only 
5, 7.5, 10, and 15 mg/kg of p-synephrine.
Oxidative stress evaluations are presented in 
Table II. Male rats treated with 100 and 150 mg/kg 
showed significant increases (p < 0.05) of 51% and 62% 
respectively in MDA values and a decrease in GSH levels 
in all treated groups. GPx activity in females showed a 
significant increase of 58% in the 75 mg/kg treated group 
compared to controls. 
Oxidative stress biomarker evaluation indicated the 
occurrence of lipid peroxidation which is characterized 
by increased MDA (Grotto et al., 2009). It is known that 
amphetamines and analogues increase the production 
of reactive species such as free radicals (Giovanni et 
al., 1995; Colado et al., 1997; Fleckenstein et al., 1997; 
Yamamoto, Zhu, 1998). Evidence shows that reactive 
oxygen species (ROS) directly or indirectly contribute 
to amphetamine toxicity mechanisms (Kovacic, Cooksy, 
2005), and although the toxic effects caused by abusive 
consumption of these substances is already known, the 
molecular factors that contribute to these effects are not 
completely understood (Frey et al., 2006).
Under basal physiological conditions, mitochondria 
are the primary source of intracellular ROS and their 
generation from mitochondria originates from complexes 
in the electron transport chain located on the inner 
mitochondrial membrane and from monoamine oxidase 
on the outer mitochondrial membrane. Thus, amphetamine 
may enhance ROS formation by promoting these basal 
mitochondrial functions. Since amphetamines cause the 
release of dopamine, another potential source of these 
ROS is from the autoxidation of dopamine via the Fenton 
reaction which uses iron as a cofactor (Graham, 1978). 
It has also been speculated that increases in intracellular 
TABLE II - Oxidative stress biomarkers evaluated in male and female Wistar rats after 28 days of oral treatment with a mixture of 
p-synephrine, ephedrine, salicin and caffeine (10:4:6:80 w/w)
Biomarkers
MALE FEMALE
Control 50 mg/kg 75 mg/kg 100 mg/kg 150 mg/kg Control 50 mg/kg 75 mg/kg 100 mg/kg 150 mg/kg
MDA (Mm) 10.5 ± 0.6 11.2 ± 0.9 13.1 ± 0.8 15.9 ± 0.9* 17.1 ± 1.2* 13.6 ± 0.7 15.4 ± 1.0 14.1 ± 1.2 16.5 ± 1.2 17.5 ± 1.1
GSH (µmol/mL erythrocytes) 6.14 ± 0.66 4.38 ± 1.1* 3.6 ± 0.65* 3.33 ± 0.27* 3.51 ± 0.47* 4.21 ± 0.55 3.13 ± 0.3 4.32 ± 0.61 4.22 ± 0.65 3.77 ± 0.5
GPx (mol NAD/min/mL) 10.9 ± 0.9 8.1 ± 0.5 9.8 ± 2.1 12.4 ± 1.4 15.5 ± 1.1 12.0 ± 1.2 13.5 ± 1.2 19.0 ± 1.6* 16.1 ± 1.1 13.8 ± 1.3
Data are expressed as mean ± standard error of the mean (n=6-8 male and 6-8 female per group). *Significantly different from their respective gender control group 
(p < 0.01) by ANOVA/Bonferroni. MDA: malondialdehyde; GSH: reduced glutathione; GPx: glutathione peroxidase.
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dopamine could lead to the formation of reactive 
dopamine quinones, which can in turn generate ROS 
(Brown, Yamamoto, 2003; Frey et al., 2006). Moreover, 
high doses of amphetamines activate glutamate receptors 
which induce the formation of superoxide radicals and 
increase calcium influx (Brown, Yamamoto, 2003) and 
mitochondrial dysfunction (Brown, Yamamoto, 2003; 
Cunha-Oliveira et al., 2006; Custodio et al., 2010). 
Both p-synephrine and ephedrine are structurally and 
pharmacologically related to amphetamine (Firenzuoli 
et al., 2005), which could be associated to the oxidative 
stress seen in this study.
Caffeine-derived effects could favor the production 
of free radicals and a subsequent increase in oxidative 
stress such as the metabolic inactivation of catecholamines 
(Halliwell, Gutteridge, 1985; Jewett et al., 1989) and 
the increase in oxidative metabolism (Shigenaga et al., 
1994; Thompson et al., 2001) including its own hepatic 
metabolism (Vistisen et al., 1992). There are also reports 
suggesting that caffeine is capable of inducing certain 
forms of oxidative damage by increasing lipid peroxidation 
(Dianzani et al., 1991). On the other hand, caffeine has 
been reported as a protective substance in cellular damage 
(Kamat et al., 2000; Krisko et al., 2005) with beneficial 
antioxidant effects (Nikolic et al., 2003) probably due to 
the main metabolites of caffeine, 1-methylxanthine and 
1-methyluric acid, which are highly effective antioxidants 
(Lee, 2000). So, the real behavior of caffeine is unclear.
There are no studies focusing on oxidative stress 
related to salicin, but aspirin (acetylsalicylic acid, which 
belongs to the same salicylate family as salicin) showed 
direct endothelial protection from oxidative damage 
at antithrombotic concentrations and demonstrated 
antioxidant and radical scavenging properties (Podhaisky 
et al., 1997).
In addition, the oxidative stress seen in the 100 and 
150 mg/kg male treated groups is confirmed by a decrease 
in GSH levels in all male treated groups. One of the most 
important roles of the GSH antioxidant system is the 
detoxification of endogenously generated peroxides. GSH 
production is considered the first line of defense against 
oxidative damage and free radical generation, where 
GSH functions as a scavenger and co-factor in metabolic 
detoxification (Nozal et al., 1997). GSH levels increased 
in mice treated orally for 28 consecutive days with 
p-synephrine (30 and 300 mg/kg) and with C. aurantium 
extracts (4000 mg/kg corresponding to 300 mg/kg of 
p-synephrine respectively) (Arbo et al., 2009a).
Interestingly, oxidative stress was not apparent in 
female rats. There were no changes in MDA or GSH levels 
with the treatment received. Some studies have reported 
gender differences in antioxidant capacity (Yamamoto 
et al., 2002; Ilhan et al., 2004) which could account for 
this finding. There is substantial evidence suggesting 
that the female hormone estrogen has potent antioxidant 
properties while the male steroid testosterone possesses no 
antioxidant activity (Yagi, Komura, 1986). Sugioka et al., 
(1987) reported that in contrast to other natural steroids, 
estrogens have a hydroxyl group in their structure which 
is also found in Vitamin E. Thus, estrogen may have 
the potential to quench peroxy radicals and terminate 
peroxidative chain reactions (Tiidus, 2000). According to 
Ayres et al. (1998), at near physiological concentrations 
in vitro, estrogen may indeed be able to directly inhibit 
superoxide production and act as a peroxidation chain 
breaking antioxidant for both lipids and DNA. Huang 
and colleagues (1999) noted the potential for estrogen to 
reduce oxidation of low density lipoproteins. In addition, 
some studies have shown that gender differences between 
male and female also exist in the antioxidant status of 
normal animals, including differences in Vitamin C and 
E levels in rats (Tiidus et al., 1999).
Gender may also affect liver glutathione status, and 
male rats have approximately 50% more reduced and total 
glutathione than females (Tiidus et al., 1999), while muscle 
activities of antioxidant enzymes superoxide dismutase, 
catalase, and glutathione peroxidase appear to be similar 
between genders in rats (Tiidus, 2000). Nevertheless, the 
results of our study showed a significant decrease in male rat 
GSH status, whereas no alterations were seen in their female 
counterparts. This fact could be explained as an organism 
response to oxidative damage, shown by MDA levels, as 
the function of GSH is to defend against oxidative damage 
and free radical generation (Nozal et al., 1997).
Alterations in GPx activity in the female 75 mg/kg 
group should be not considered as it did not show a linear 
profile. According to Lewis et al. (2002), some factors can 
be useful in differentiating between a significant change 
from control values and a treatment-related effect. This 
difference is less likely to be an effect of treatment if: there 
is no obvious dose response; it is due to findings in one 
or more animals that could be considered outliers; or it is 
normal biological variation (within reference value limits).
CONCLUSION
In this experimental work we evaluated a 28-day 
period of oral exposure to a mixture of p-synephrine, 
ephedrine, salicin, and caffeine, which has been used 
in weight loss formulations. Our findings indicate that 
the continued use of the mixture can produce changes 
in hepatic and kidney function and in oxidative stress 
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biomarkers; these are more pronounced in males than 
females. More studies are necessary to clarify gender 
differences in sub-chronic toxicity profile and the protector 
role of estrogen against the effect of the mixture in females.
Further investigations should include long-term 
toxicity studies to better explain the effects of the mixture, 
as well as determine other oxidative stress and biochemical 
(hepatic and renal) markers. Products containing this 
mixture should be used with caution until the toxicological 
profile has been fully elucidated, whereas the number 
of toxicological accidents related to the use of dietary 
supplements whose formulations often vary, is very 
frequent.
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